Stay updated on Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page content appears unchanged; the Study Details page for NCT02437071 and its sections (Overview, Eligibility Criteria, Study Plan, and Interventions) remain the same.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedCore content updated to inform users about funding-related operating status and current NIH Clinical Center openness; version updated from v3.1.0 to v3.2.0.SummaryDifference3%

- Check49 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

- Check56 days agoChange DetectedChanged the page state from No Results Posted to Results Submitted, indicating that results have been provided/submitted.SummaryDifference0.1%

- Check63 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 (Revision: v3.0.2 added). The 'Back to Top' link was removed, with no other substantive content changes evident.SummaryDifference0.2%

- Check70 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.